Down-regulation of survivin expression reversed multidrug resistance in adriamycin-resistant HL-60/ADR cell line

Acta Pharmacologica Sinica

Volumn 24, Issue 12, 2003, Pages 1235-1240

  Wang, Lei ^a   Zhang, Gui Mei ^a   Feng, Zuo Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antisense RNA; Apoptosis; Caspase 3; Doxorubicin; HL 60 cells; Multiple drug resistance; Survivin

Indexed keywords

COMPLEMENTARY RNA; DOXORUBICIN; MESSENGER RNA; PLASMID DNA; SURVIVIN;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; COLORIMETRY; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; EUKARYOTE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; WESTERN BLOTTING;

APOPTOSIS; CASPASE 3; CASPASES; DOWN-REGULATION; DOXORUBICIN; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HL-60 CELLS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PLASMIDS; RNA, ANTISENSE; RNA, MESSENGER; TRANSFECTION;

EID: 0345530044     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdoff T, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998; 58: 5315-20.
2. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-21.
3. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580-3.
4. John CR. The survivin saga goes in vivo. J Clin Invest 2001; 108: 965-9.
5. Jaattela M. Escaping cell death: survivial proteins in cancer. Exp Cell Res 1999; 248: 30-43.
6. Kutter F, Angonin R, Ferrand C, Deconinck E, Mougin C, Cahn JY. Relationship between expression of genes involved in cell cycle control and apoptosis in diffuse large B lymphoma: a preferential survivin-cyclin B link. Leukemia 2002; 16: 726-35.
7. Mori A, Wada H, Nishimura Y, Okamoto Y, Kakishita E. Expression of the antiapoptosis gene survivin in human leukemia. Int J Hematol 2002; 75: 161-5.
8. Notarbartolo M, Cervello M, Dusonchet L, Cusimano A. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis protein). Cancer 2002; 180: 91-101.
9. Tajiri T, Tanaka S, Shono K, Kinoshita Y. Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma. Cancer Lett 2001; 166: 89-94.
10. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998; 17: 3247-59.
11. Ambrosini G, Adida C, Sirugo G, Altieri DC. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 1998; 273: 11177-82.
12. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998; 152: 43-9.
13. Grossman D, McNiff JM, Li F, Altieri DC. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 1999; 79: 1121-26.
14. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-32.
15. Suzuki A, Shiraki K. Tumor cell "dead or alive": caspase and survivin regulate cell death, cell cycle and cell survival. Histol Histopathol 2001; 16: 583-93.